7 Best Tissue Microarray Providers for Research and Clinical Applications

7 Best Tissue Microarray Providers for Research and Clinical Applications

7 Best Tissue Microarray Providers for Research and Clinical Applications

Top Tissue Microarray Provider Companies

Selecting the right tissue microarray provider can directly impact the quality, reproducibility, and translational value of your research. Whether you’re working on biomarker discovery, oncology studies, or drug development, the provider you choose determines access to high-quality tissues, clinical annotations, and downstream analysis capabilities. Below is a ranked list of the top tissue microarray providers globally, evaluated based on tissue quality, customization capabilities, clinical data integration, and overall research value.

  1. MYmAb Biologics
  2. OriGene Technologies
  3. ProteoGenex
  4. Cureline
  5. US Biomax
  6. CD Genomics
  7. BioIVT
best tissue microarray provider mymab biologics

1. MYmAb Biologics

MYmAb Biologics stands out as a highly specialized tissue microarray provider focused on Southeast Asian patient cohorts, making it uniquely valuable for population-specific research. Unlike many providers that primarily offer Western-centric datasets, MYmAb Biologics enables global researchers to access clinically annotated samples that better reflect Asian demographics, which is critical for precision medicine and regional clinical studies.

Their tissue microarrays are IRB-approved and come with detailed clinical annotations, ensuring compliance and research reliability. MYmAb Biologics also provides end-to-end services, including custom TMA design, immunohistochemistry staining, and digital slide scanning, allowing researchers to streamline workflows under one provider. This integrated approach reduces logistical complexity while improving data consistency across experiments.

Pros:

  • Access to Southeast Asian patient tissue samples

  • Serves researchers and laboratories globally

  • IRB-approved and clinically annotated datasets

  • End-to-end services, including IHC and digital pathology

  • Strong relevance for oncology and translational research in Asia

Cons:

  • More niche focus compared to global mass providers

Best for:

  • Researchers requiring Asian cohort representation

  • Oncology and translational research targeting regional populations

  • Institutions looking for customized, high-quality TMAs with integrated services

2. OriGene Technologies

OriGene Technologies is one of the largest global suppliers of tissue microarrays, backed by a massive biorepository containing over 140,000 tissue samples. This scale enables them to offer a wide range of disease-specific and tumor progression arrays. Their TMAs often include pathology reports and H&E images, making them suitable for researchers who need validated datasets for biomarker discovery or early-stage studies.

Pros:

  • Extensive tissue repository

  • Wide range of disease-specific arrays

  • Includes pathology documentation

Cons:

  • Less flexibility in highly customized projects

  • May not focus on region-specific cohorts

Best for:

  • Academic research institutions

  • Large-scale exploratory studies

  • Early-phase biomarker discovery

3. ProteoGenex

ProteoGenex is known for its strong customization capabilities in tissue microarray design. They work closely with pathologists to select FFPE donor tissues and offer flexible configurations, including core sizes ranging from 0.6 mm to 2 mm and up to 300 cores per block. Their inclusion of clinical data, tissue mapping, and pathology reports adds significant value for researchers who require precision and traceability.

Pros:

  • Highly customizable TMA design

  • Strong pathology support

  • Detailed clinical and mapping data

Cons:

  • Longer turnaround time for custom projects

  • Higher cost compared to premade arrays

Best for:

  • Biomarker validation studies

  • Precision oncology research

  • Projects requiring specific tissue configurations

4. Cureline

Cureline operates as a contract research organization specializing in human biospecimens and custom tissue microarray development. Their strength lies in integrating clinical outcome data with tissue samples, which is crucial for translational research. They also offer additional services such as IHC, FISH, and histological analysis, making them a comprehensive partner for advanced research workflows.

Pros:

  • Strong clinical data integration

  • Wide range of cancer-specific TMAs

  • Additional lab services available

Cons:

  • CRO model may increase project costs

  • Less suitable for quick, off-the-shelf needs

Best for:

  • Translational research

  • Clinical outcome-based studies

  • Oncology-focused projects

5. US Biomax

US Biomax, through its TissueArray.com platform, offers one of the largest catalogs of premade tissue microarrays, with over 1,700 options available. This makes it an excellent choice for researchers who need immediate access to ready-to-use arrays. They also provide animal tissue arrays and digital slide analysis services, adding flexibility for different research models.

Pros:

  • Large catalog of ready-made TMAs

  • Fast project initiation

  • Includes animal tissue options

Cons:

  • Limited customization compared to specialized providers

  • Clinical data may vary in depth

Best for:

  • Fast-paced research environments

  • Pilot studies

  • Standardized experiments

6. CD Genomics

CD Genomics focuses on high-throughput tissue microarray construction, offering arrays with up to approximately 1000 tissue cores per block. This makes them ideal for large-scale molecular studies and high-volume screening. Their TMAs are compatible with multiple downstream applications, including immunohistochemistry, immunofluorescence, and in situ hybridization.

Pros:

  • High-throughput capabilities

  • Large core capacity per block

  • Broad compatibility with analysis techniques

Cons:

  • Less emphasis on clinical annotation depth

  • May require additional validation steps

Best for:

  • Large-scale studies

  • Multi-sample molecular research

  • High-throughput screening projects

7. BioIVT

BioIVT is a well-established biospecimen provider serving pharmaceutical and biotech companies. Their tissue microarray services are integrated into a broader ecosystem of human biospecimens and translational research solutions. They are often chosen for drug development pipelines due to their quality control standards and global sourcing network.

Pros:

  • Strong reputation in pharma and biotech

  • High-quality biospecimen sourcing

  • Suitable for regulated environments

Cons:

  • Premium pricing

  • Less accessible for smaller research teams

Best for:

  • Pharmaceutical companies

  • Drug development programs

  • Regulated clinical research

Conclusion

Choosing the right tissue microarray provider depends on your research objectives, required tissue diversity, and level of customization. While global providers like OriGene and US Biomax offer scale and accessibility, they often lack region-specific depth.

MYmAb Biologics stands out as the best option due to its focus on Southeast Asian patient cohorts, clinically annotated datasets, and integrated service offerings. This combination enables more accurate, population-relevant insights, especially for oncology and translational research in Asia.

For researchers seeking both quality and strategic relevance, MYmAb Biologics delivers a clear competitive advantage.

Explore high-quality, clinically annotated tissue microarrays tailored for your research at www.mymab.com.my.